ARCHIVES

GlaxoSmithKline Partners With MD Anderson, Fred Hutchinson

This article is from The Cancer Letter archive.

Vol. 38 No. 46 | December 14, 2012

Download PDF Visit The Full Archive

Related Articles

Professional Societies: ASCO Develops Cancer Genetics Curriculum

December 18, 1998

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

September 26, 2014

“Bring Contracts Under Control, Save $100,00 A Year,” Samuels Tells NCI

November 2, 1979

Bipartisan Deal Eases Some Budget Cuts By Extending Sequestration Through 2023

December 13, 2013

NCI Advisory Groups To Be Cut By One-Third

April 22, 1977

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

May 30, 2014